1. KIF14 mediates cabazitaxel-docetaxel cross-resistance in advanced prostate cancer by promoting AKT phosphorylation
   Lina Liu et al, 2023, Archives of Biochemistry and Biophysics CrossRef
2. The effect of baseline O2 conditions on the response of prostate cancer cells to hypoxia
   Ricardo Alva et al, 2024, American Journal of Physiology-Cell Physiology CrossRef
3. Extracellular Vesicles and Cell Pathways Involved in Cancer Chemoresistance
   Lara Console et al, 2022, Life CrossRef
4. A comprehensive gene expression profile analysis of prostate cancer cells resistant to paclitaxel and the potent target to reverse resistance
   Ping Che et al, 2022, Human & Experimental Toxicology CrossRef
5. Ritonavir reverses resistance to docetaxel and cabazitaxel in prostate cancer cells with acquired resistance to docetaxel
   Eric van der Putten et al, 2024, Cancer Drug Resistance CrossRef
6. Identification of blood lipid markers of docetaxel treatment in prostate cancer patients
   Morgan C. Finnerty et al, 2024, Scientific Reports CrossRef
7. Targeting the Mitochondria with Pseudo-Stealthy Nanotaxanes to Impair Mitochondrial Biogenesis for Effective Cancer Treatment
   Lulu Ren et al, 2022, ACS Nano CrossRef
8. Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance
   Yujie Huang et al, 2022, Drug Design, Development and Therapy CrossRef
9. Anticancer properties of complexes derived from bidentate ligands
   David Izuchukwu Ugwu et al, 2023, Journal of Inorganic Biochemistry CrossRef
10. Establishment and characterization of the gemcitabine-resistant human gallbladder cancer cell line NOZ GemR
    Ming Xu et al, 2024, Annals of Medicine & Surgery CrossRef